Stop the pain: Tips for increasing patient retention and decreasing missing data in analgesia clinical trials
Rho
09-Feb-2012 - Outsourcing-Pharma presents its latest round-up of the appointments within the pharmaceutical industry, including news from Icon, Merck and Clinipace.
07-Feb-2012 - Logistics contractor Marken plans to ramp up its activities in China with a new Beijing depot set to open later this year.
06-Feb-2012 - The desire to be an all-encompassing ‘one stop shop’ may be common to both contract research organisations (CRO) and contract manufacturing organisations (CMO), but that does not mean the terms CRO and CMO are synonymous according to industry leaders.
02-Feb-2012 - Outsourcing-Pharma presents its weekly round-up of the latest career changes within the pharmaceutical industry, including news from Icon, AbelsonTaylor and Chiltern.
02-Feb-2012 - Almac says its first leap into Next Generation Sequencing (NGS) data analysis services is a much needed-change from the industry’s current “one-size-fits-all” offering.
02-Feb-2012 - Trial logistics firm Marken says new expert development team will create ‘industry changing,’ cold chain technologies.
31-Jan-2012 - TNT Express is now offering temperature-controlled logistics services to support global distribution of biologics.
30-Jan-2012 - HUYA Bioscience says it will strengthen bonds between Chinese drug innovators and worldwide developers and through its new partnership with the Tianjin Institute of Pharmaceutical Research (TIPR).
26-Jan-2012 - Outsourcing-Pharma presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Patheon, Wolfe Laboratories, and Premier Research.
25-Jan-2012 - Clinical Financial Services (CFS) has made its first foray into the global market after opening a new office in Edinburgh, Scotland.
24-Jan-2012 - Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
23-Jan-2012 - Almac says its isotope chemistry facility and its lab division both passed UK regulators’ inspections.
19-Jan-2012 - SGS’ new analytical lab in Mumbai, India will open later this week just six months after the analytical services firm began its construction .
19-Jan-2012 - InVentiv will boost its market research and analytics offering with the acquisition of SDI’s medical audit activities.
19-Jan-2012 - Outsourcing-Pharma presents its weekly round-up of the latest career changes in the pharmaceutical industry, including news from Premier Research, Almac, and AAI Pharma.
18-Jan-2012 - Quintiles has invested £3m ($4.6m) in a new UK-based biomarker R&D company in a continuation of its efforts to build in the field of personalised medicines.
18-Jan-2012 - Training and consultancy firm NSF Health Sciences (NSF-DBA) has acquired Pink Associates in a bid to broaden its service offering.
17-Jan-2012 - inVentiv Health says it will now offer a one-stop-shop for pharma and biotech training services after merging its subsidiaries Pharmaceutical Institute and Preceptiv Learning Solutions.
16-Jan-2012 - Contract services firm Warnex will leave the Toronto Stock Exchange (TSX) after failing to meet the requirements for continued listing.
11-Jan-2012 - ShangPharma has revealed its newly opened 100,000 sq foot facility will serve the growing capacity needs of pharma giant Eli Lilly.
10-Jan-2012 - Sigma-Aldrich says it is a step closer to becoming a one-stop-shop for biopharmas in the drug discovery process after it inked a takeover agreement with biological testing firm BioReliance.
10-Jan-2012 - AMRI has begun reviewing its chemistry services operation in Hungary and says it may cut jobs and shift work to other facilities.
09-Jan-2012 - Outsourcing-Pharma presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Mylan, Aegate, and Intralinks.
09-Jan-2012 - Albany Molecular Research (AMRI) says ‘streamlining’ plan will focus on its drug licensing unit not its contract API research, development and manufacturing services division.